Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program
Go back to Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 255.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $255.43 | 52 Week High | $160.00 | |||
| Open | $255.43 | 52 Week Low | $95.80 | |||
| Day High | $255.43 | P/E | 47.48 | |||
| Day Low | $255.43 | EPS | $5.38 | |||
| Volume | 66 | |||||
